MFG Q1 2026 Earnings Strong EPS Beat of 284 as Net Interest Income Rises Yet Stock Edges Lower EW Q1 2026 Earnings EPS Beat Drives Stock Higher Amid Limited Revenue Disclosure Black Diamond Therapeutics BDTX Q1 2026 Earnings EPS Beat Fails to Lift Stock as Pipeline Uncertainty Lingers NUVB Q1 2026 Earnings Small EPS Beat Fails to Lift Shares Amid PreRevenue Stage KROS Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Amid Pipeline Progress CRVL Q1 2026 Earnings EPS of 061 Reported Stock Declines 285